vimarsana.com

Page 5 - ஆராய்ச்சியாளர்கள் இல் பேலர் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health gambles with Indian vaccine - Health

JEMIMA BEUKES WINDHOEK The health ministry is pushing ahead with negotiations for Covishield vaccines despite concerns of its lack of effectiveness against the South African coronavirus variant currently spreading in Namibia. Covishield is Serum Institute of India s (SII) version of the AstraZeneca-Oxford vaccine that is being produced in collaboration with the University of Oxford. Government talks are taking place at a time when the South African government sold off one million doses of the AstraZeneca vaccines acquired from SII. Correspondence between the health ministry’s head of procurement at the Central Medical Store (CMS), Fabiola Vahekeni, and SII suggests the ministry is willing to negotiate conditions in order receive a delivery of the vaccines.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.